Sorrento Therapeutics Inc (SRNE)

[dia76ca]

I agree with those who say that we should expect ABIVERTINIB news any time now. We may in fact receive at least 4 news releases.

1. We may hear about successful trial results from Brazil and the US in the use of ABIVERTINIB to prevent and treat Covid cytokine storm.

2. This news should be followed by news of EUA approvals around the world.

3. We may also hear about marketing approval for ABIVERTINIB in NSCLC in China.

4. On June 2, 2021 , over three months ago, Sorrento issued a press release stating, "Sorrento is seeking major global partnership(s) to co-develop and co-commercialize ABIVERTINIB." Such a partnership would presumably cover not only the Covid application but also NSCLC, many other cancers and autoimmune diseases.

ABIVERTINIB has blockbuster applications to many indications. Any partnership(s) would be worth many hundreds of millions. The worldwide Covid EUA approvals in themselves would be a game-changer!